More
Other news
Cervical Cancer Elimination Day of Action 2024: celebrating front-line workers and transforming global commitments into life-saving actions
The Cervical Cancer Elimination Day of Action on 17 November 2024 marks the fourth year of a glob...
18.11.2024
Read more
A prospective cohort study comparing efficacy of 1 dose of quadrivalent human papillomavirus vaccine to 2 and 3 doses at an average follow up of 12 years postvaccination
Scientists from the International Agency for Research on Cancer (IARC) and partner institutions h...
12.11.2024
Read more
Leveraging single-dose human papillomavirus vaccination dose-efficiency to attain cervical cancer elimination in resource-constrained settings
In a new paper, researchers from the International Agency for Research on Cancer (IARC) show that...
12.11.2024
Read more